Serum Beta-Trace Protein versus Glomerulus Filtration Rate as a Predictor for Kidney Function among Hypertensive Patients

Authors

  • Ranisa Handayani Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar
  • Yuyun Widaningsih Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar
  • Fitriani Mangarengi Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar
  • Uleng Bahrun Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

DOI:

https://doi.org/10.24293/ijcpml.v27i2.1618

Keywords:

Serum beta-trace protein, glomerular filtration rate, hypertension

Abstract

Beta-Trace Protein (BTP) is a low-molecular-weight glycoprotein that can convert prostaglandin H2 into prostaglandin D2 and is associated with the vascular function's alteration. Serum beta-trace protein has been proposed as a promising marker in predicting kidney function in hypertensive patients. This study aimed to analyze the correlation between BTP and glomerulus filtration rate, particularly in hypertensive patients. A cross-sectional survey was conducted on 70 hypertensive participants admitted to Dr. Wahidin Sudirohusodo Hospital from July-August 2019. Beta-trace protein, serum urea, creatinine, blood pressure, and anthropometric were measured. The Glomerulus Filtration Rate (GFR) with Cockcroft Gault was graded using GFR stages. The hypertension was graded according to the category of the European Society of Cardiology (ESC) 2018. A descriptive test, Kruskal-Wallis test, Fisher exact test, Spearman correlation test, and logistic regression test were performed at a confidence level of 95%. Significant differences were found between the age, systole, diastole, blood urea, creatinine, and GFR (p=< 0.05). There was a significant difference between GFR and the degree of hypertension (p=< 0.001), but no differences were found in the mean value of BTP and the degree of hypertension (p=0.348). A significant negative correlation was found between GFR and BTP (p=0.028, r = -0.263). Logistic regression test s showed that the increased BTP led to 2.591 times greater possibility of end-stage renal disease with GFR < 15 mL/min/ 2 1.73 m (crude odds ratio 95% CI 1.168-5.475). Serum beta-trace protein possesses a prognostic ability of glomerulus filtration rate and can be used to predict the odd of end-stage renal disease in hypertensive patients.

Downloads

Download data is not yet available.

Author Biographies

Ranisa Handayani, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Yuyun Widaningsih, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Fitriani Mangarengi, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Uleng Bahrun, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

References

Kementerian Kesehatan Republik Indonesia. H i p e rt e n s i [ I n t e r n e t] . A v a i l a b l e fr o m :

http://www.depkes.go.id. (accessed 2 June, 2019).

Whelton Paul K, Carey RM, Aronow WS, Casey Jr. DE, Collins KJ, et al. Guideline for the prevention,

detection, evaluation, and management of high blood pressure in adults. Journal of the American College of Cardiology, 2017; 71(19): e127-248.

Brenner GM, Stevens CW. Antihypertensive drugs. In: Brenner and Steven's pharmacology. 5 Ed.,

Philadelphia, Elsevier, 2018; 10: 103-115.

Lukito AA, Harmeiwaty E, Hustrini NM. Klasifikasi tekanan darah klinik. Dalam: Konsensus penatalaksanaan hipertensi 2019. 1 Ed., Jakarta, Perhimpunan Dokter Hipertensi Indonesia, 2019; 7-8.

Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D'Avino A, De Leon J. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis,

; 278: 49-59.

White CA, Ghaza-Shahi S, Adams MA. íŸ-trace protein: A marker of GFR and other biological pathways.

American Journal of Kidney Diseases, 2015; 65(1): 131-146.

Donadio C, Bozzoli L. Urinary beta-trace protein: Unique biomarker to screen early glomerular filtration rate impairment. Medicine, 2016; 95(49): e5553.

Song W, Ricciotti E, Liang X, Grosser T, Grant GR, et al. Lipocalin-like prostaglandin D synthase but not

hemopoietic prostaglandin d synthase deletion causes hypertension and accelerates thrombogenesis in mice. The Journal of Pharmacology and Experimental Therapeutics, 2018; 367(3): 425-432.

Hirasawa N, Uehara Y, Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, et al. Lipocalin–type prostaglandin D synthase in essential hypertension. Hypertension 39 (part 2), 2002; 449 – 454.

James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease.

Asian Pacific Society of Nephrology, 2010; 53-56.

Bhavsar NA. Appel LJ, Kusek JW, Contreras G, Bakris G, et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. American Journal of Kidney Disease, 2011; 58(6): 886-893.

Pandya Divya, Nagrajappa Anil Kumar, Ravi KS. Assessment and correlation of urea and creatinine

levels in saliva and serum patients with chronic kidney disease, diabetes, and hypertension-a research study. Journal of Clinical and Diagnostic Research, 2016; 10(10): 58-62.

Mohammed Kidher Mudher, Ewadh Mufeed Jalil, Hamza Amer. Beta-trace protein level as a better

diagnostic marker of renal impairment in patients with chronic kidney disease, diabetes mellitus, and renal transplants. Journal of Pharmaceutical Sciences and Research, 2018; 10(6): 1615- 1618.

Bacci MR, Cavallari MR, de Rozier-Alver RM, Alves BCA, Fonseca FLA. The impact of lipocalin-type

prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes. Drug Design,

Development, and Therapy, 2015; 22(9): 3179-3182.

Orenes-Pinero E, Manzano-Fernandez S, LopezCuenca A, Marin F, Valdes M, Januzzi JL. Beta-trace protein: From GFR marker to cardiovascular risk predictor. Clinical Journal of American Society of Nephrology, 2013; 8: 873-881.

Spannaus KS, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von Eckardstein A. Serum creatinine,

cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. American Association of Clinical Chemistry, 2010; 56(5): 740-749

Downloads

Submitted

2020-01-29

Accepted

2021-01-04

Published

2021-04-15

How to Cite

[1]
Handayani, R., Widaningsih, Y., Mangarengi, F. and Bahrun, U. 2021. Serum Beta-Trace Protein versus Glomerulus Filtration Rate as a Predictor for Kidney Function among Hypertensive Patients. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 27, 2 (Apr. 2021), 127–131. DOI:https://doi.org/10.24293/ijcpml.v27i2.1618.

Issue

Section

Articles